Apogee Therapeutics, Inc. Common Stock
Symbol: APGE (NASDAQ)
53.83
▲ (0.65%) 0.345
Company Description:
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating antibody engineering to optimize half-life and other properties.
Key Stats
- Today's Open: $53.77
- Today's High: $55.225
- Today's Low: $52.02
- Today's Volume: 515.75K
- Yesterday Close: $53.48
- Yesterday High: $55.85
- Yesterday Low: $52.86
- Yesterday Volume: 501.30K
- Last Min Volume: 2
- Last Min High: $53.825
- Last Min Low: $53.825
- Last Min VWAP: $53.825
Company Profile
- Name: Apogee Therapeutics, Inc. Common Stock
- Website: https://www.apogeetherapeutics.com
- Listed Date: 2023-07-14
- Location: WALTHAM, MA
- Market Status: Active
- CIK Number: 0001974640
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $3.78B
- Round Lot: 100
- Outstanding Shares: 67.65M
- Asset Type: CS
RECENT FILINGS FOR APGE
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-10-15 | 4 | View |
| 2025-10-14 | SCHEDULE 13D/A | View |
| 2025-10-10 | 8-K | View |
| 2025-10-10 | 424B5 | View |
| 2025-10-08 | 424B5 | View |
| 2025-10-03 | 4 | View |
| 2025-09-05 | 4 | View |
| 2025-08-11 | 10-Q | View |
| 2025-08-11 | 8-K | View |
| 2025-08-08 | 4 | View |
| 2025-08-06 | SCHEDULE 13G/A | View |
| 2025-08-05 | SCHEDULE 13G/A | View |
| 2025-08-05 | SCHEDULE 13G/A | View |
| 2025-07-16 | SCHEDULE 13G/A | View |
| 2025-07-07 | 8-K | View |
| 2025-07-03 | 4 | View |
| 2025-07-02 | 144 | View |
| 2025-06-23 | 8-K | View |
| 2025-06-20 | 4 | View |
| 2025-06-20 | 4 | View |
Latest News on APGE